Philips Gains FDA Clearance for AI-Driven Cardiac Imaging Tool

Philips has secured 510(k) clearance from the U.S. Food and Drug Administration for its latest cardiac imaging software, developed in partnership with Edwards Lifesciences. The solution, EchoNavigator R5.0 with DeviceGuide, uses artificial intelligence to create real-time 3D visualizations that support physicians during mitral valve repair procedures.

Traditionally, clinicians rely on X-ray fluoroscopy and 3D transesophageal echocardiography, which generate separate images that must be interpreted together. This can complicate device positioning. The new system integrates both imaging streams into a single view, enabling more precise tracking and placement of repair devices.

Designed for use with Edwards’ Pascal Ace system, the technology aims to enhance procedural accuracy and team coordination. Early clinical feedback indicates improved communication and usability, highlighting its potential to simplify complex minimally invasive heart procedures and support better patient outcomes.

31-03-2026